Dr. Innis-Shelton is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
619 19th St S
Birmingham, AL 35249Phone+1 205-934-4011Fax+1 205-297-9411
Education & Training
- University of Virginia Medical CenterFellowship, Hematology and Medical Oncology, 2006 - 2008
- Wellstar Health System/Wellstar Cobb HospitalResidency, Internal Medicine, 1998 - 2001
- Medical College of Georgia at Augusta UniversityClass of 1998
Certifications & Licensure
- CA State Medical License 2001 - Present
- AL State Medical License 2008 - 2024
- VA State Medical License 2006 - 2008
- GA State Medical License 2001 - 2001
- American Board of Internal Medicine Hematology
Clinical Trials
- Fludarabine / Total Body Irradiation Regimen for ALLO HCT in Acute Lymphoblastic Leukemia Start of enrollment: 2013 Aug 27
- Post Transplant Cyclophosphamide (Cytoxan) for GvHD Prophylaxis Start of enrollment: 2013 Aug 27
- Safety of Post-transplant Alpha-beta Depleted T-cell Infusion Following Haploidentical Stem Cell Transplant (Haplo SCT) Start of enrollment: 2014 Oct 09
- Join now to see all
Publications & Presentations
PubMed
- 23 citationsDetection of microsatellite instability-high (MSI-H) by liquid biopsy predicts robust and durable response to immunotherapy in patients with pancreatic cancer.Sakti Chakrabarti, Leslie Bucheit, Jason Scott Starr, Racquel Innis-Shelton, Ardaman Shergill
Journal for Immunotherapy of Cancer. 2022-06-01 - 29 citationsFamily history of hematologic malignancies and risk of multiple myeloma: differences by race and clinical featuresMaryAnn E. VanValkenburg, Gwendolyn I. Pruitt, Ilene Brill, Luciano J. Costa, Maryam Ehtsham
Cancer Causes & Control. 2016-01-01 - 10 citationsMobilization of Hematopoietic Progenitor Cells for Autologous Transplantation Using Pegfilgrastim and Plerixafor: Efficacy and Cost ImplicationsNicole Watts, Marisa B. Marques, Daniel B. Peavey, Racquel Innis-Shelton, Ayman Saad
Biology of Blood and Marrow Transplantation. 2019-02-01
Abstracts/Posters
- A Phase II Clinical Trial of Post-Transplant Cyclophosphamide for Graft Versus Host Disease Prevention Following Myeloablative Peripheral Blood Stem Cell Matched Unrel...Racquel Innis-Shelton, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Daratumumab, Carfilzomib, Lenalidomide and Dexamethasone (Dara-KRd) Induction, Autologous Transplantation and Post-Transplant, Response-Adapted, Measurable Residual Di...Racquel Innis-Shelton, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: